What is ABEO stock price today?

ABEO (Abeona Therapeutics Inc) stock is trading at $5.31 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is ABEO stock going up or down today?

ABEO stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ABEO stock now?

The decision to buy ABEO depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ABEO a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ABEO based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ABEO stock overvalued or undervalued?

ABEO currently trades at a P/E ratio of 4.34, which may suggest attractive valuation. Our DCF calculator provides intrinsic value estimates to help determine if ABEO is fairly priced.

What is ABEO's P/E ratio?

ABEO has a price-to-earnings (P/E) ratio of 4.34, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is ABEO's market cap?

ABEO (Abeona Therapeutics Inc) has a market capitalization of $0.28 billion, making it a small-cap stock.

What is ABEO's price to book ratio?

ABEO trades at a price-to-book (P/B) ratio of 1.66, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does ABEO pay dividends?

ABEO does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ABEO's dividend yield?

ABEO does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ABEO stock a good long-term investment?

ABEO's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ABEO's revenue growth rate?

ABEO has shown revenue growth of -1.0% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Yes, ABEO is profitable with a profit margin of 205.9%. This indicates the company generates 205.9 cents of profit for every dollar of revenue.

What are the risks of investing in ABEO?

Key risks for ABEO include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ABEO compare to its competitors?

Compare ABEO to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ABEO's performance and positioning.

What is ABEO's stock price target for 2026?

Our AI model provides price targets for ABEO based on fundamental analysis: Bull case $6.90 (+30%), Base case $6.11 (+15%), Bear case $4.78 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about ABEO?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ABEO. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ABEO's next earnings report?

ABEO reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ABEO - Abeona Therapeutics Inc

NYSE * Healthcare * Biotechnology

$5.31

+$0.06 (+1.14%)

About Abeona Therapeutics Inc

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is pz-cel, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.

ABEO Key Statistics

Market Cap

$284.50M

P/E Ratio

4.34

P/B Ratio

1.66

EPS

$1.21

Revenue Growth

-1.0%

Profit Margin

205.9%

Employees

136

How ABEO Compares to Peers

ABEO has the lowest P/E ratio in Biotechnology, suggesting it may be the most undervalued

ABEO has the highest profit margins in Biotechnology

ABEO is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

of 6

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ABEO(This stock)	$284.50M	4.3	-1%	205.9%	-
AMGNAmgen Inc	$177.92B	25.6	0%	0.2%	vs AMGN
GILDGilead Sciences	$154.99B	19.3	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$113.16B	31.1	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$77.69B	17.6	0%	0.3%	vs REGN
BIIBBiogen Inc	$24.26B	15.1	0%	0.2%	vs BIIB

Abeona Therapeutics Inc Company Information

Headquarters: 6555 Carnegie Avenue, Cleveland, OH, United States, 44103, undefined
Website: www.abeonatherapeutics.com
Sector: Healthcare
Industry: Biotechnology

ABEO - Abeona Therapeutics Inc

About Abeona Therapeutics Inc

ABEO Key Statistics

How ABEO Compares to Peers

Abeona Therapeutics Inc Company Information

ABEO Lician Score

ABEO Financial Snowflake

Upcoming Events for ABEO